ZA975755B - Useful formulations of acid addition salt drugs. - Google Patents

Useful formulations of acid addition salt drugs.

Info

Publication number
ZA975755B
ZA975755B ZA9705755A ZA975755A ZA975755B ZA 975755 B ZA975755 B ZA 975755B ZA 9705755 A ZA9705755 A ZA 9705755A ZA 975755 A ZA975755 A ZA 975755A ZA 975755 B ZA975755 B ZA 975755B
Authority
ZA
South Africa
Prior art keywords
acid addition
addition salt
useful formulations
salt drugs
drugs
Prior art date
Application number
ZA9705755A
Inventor
Ronald W Pero
Original Assignee
Oxigene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxigene Inc filed Critical Oxigene Inc
Publication of ZA975755B publication Critical patent/ZA975755B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/541Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9705755A 1996-06-28 1997-06-27 Useful formulations of acid addition salt drugs. ZA975755B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67334196A 1996-06-28 1996-06-28

Publications (1)

Publication Number Publication Date
ZA975755B true ZA975755B (en) 1998-02-23

Family

ID=24702259

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9705755A ZA975755B (en) 1996-06-28 1997-06-27 Useful formulations of acid addition salt drugs.

Country Status (7)

Country Link
EP (1) EP0954327A1 (en)
JP (1) JP2000516204A (en)
AU (1) AU738165B2 (en)
CA (1) CA2258965A1 (en)
IL (1) IL127691A0 (en)
WO (1) WO1998000159A1 (en)
ZA (1) ZA975755B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303671B1 (en) 1998-07-28 2001-02-23 Nicox Sa SALTS OF NITRIC ACID WITH ACTIVE DRUGS IN THE TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM
JP2004507504A (en) * 2000-08-28 2004-03-11 シントン・ベスローテン・フェンノートシャップ Paroxetine composition and method for producing the same
JP2006028028A (en) * 2004-07-12 2006-02-02 Teikoku Medix Kk Oral medicinal composition
BRPI0503734A (en) * 2005-08-23 2007-04-27 Cristalia Prod Quimicos Farm pharmaceutical composition in ready-to-use morphine solution for injection and unit dosage form of morphine for epidural or intrathecal administration
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
PT2968729T (en) 2013-03-14 2018-11-06 Fresenius Kabi Deutschland Gmbh Packaging system for oxygen-sensitive drugs
BR112015021586B1 (en) 2013-03-14 2023-01-31 Fresenius Kabi Deutschland Gmbh INJECTABLE PHARMACEUTICAL MORPHINE FORMULATION AND KIT
CN118021718B (en) * 2024-04-12 2024-07-02 成都瑞尔医药科技有限公司 Propafenone hydrochloride injection and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2000025A (en) * 1977-05-14 1979-01-04 Pfizer Ltd Nitroimidazole formulations
US4536386B1 (en) * 1981-01-26 1995-03-07 Robins Co Inc A H Method of controlling emesis caused by cisplatin in cancer chemotherapy
PH22107A (en) * 1984-06-07 1988-06-01 Takeda Chemical Industries Ltd 3-pyrazolo(1,5-a)pyrdinium cephem compounds
US5260289A (en) * 1992-06-12 1993-11-09 Vitacain Pharmaceutical Co., Ltd. Composition for treating pain, method for treating pain and composition for reinforcing pain relief action

Also Published As

Publication number Publication date
IL127691A0 (en) 1999-10-28
WO1998000159A1 (en) 1998-01-08
AU738165B2 (en) 2001-09-13
AU3407597A (en) 1998-01-21
JP2000516204A (en) 2000-12-05
EP0954327A1 (en) 1999-11-10
CA2258965A1 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
AU3455297A (en) Pharmaceutical composition containing acid addition salt of basic drug
PL334997A1 (en) Derivatives or arylosulphonyl-hydroxamic acid
ZA965866B (en) 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
ZA9610650B (en) 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
GB9713149D0 (en) Pharmaceutical formulations
ZA967745B (en) Pharmaceutical formulations.
SG79255A1 (en) Pharmaceutical formulations
HUP0100059A3 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
HU9801044D0 (en) Sulfonyl-amino-carboxylic acid derivatives
IL135177A0 (en) Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same
IL130334A0 (en) Pharmaceutical aminophosphonic acid derivatives
HUP0000777A3 (en) Resolution of ritalinic acid salt
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
ZA200007415B (en) Amino acid derivatives and drugs containing the same as the active ingredient.
PL340461A1 (en) Derivatives of isothiazocarboxylic acid
AU5761998A (en) Pharmaceutical aminophosphonic acid derivatives
IL136612A (en) Phenylaminoalkyl-carboxylic acid derivatives and pharmaceutical compositions containing the same
ZA975755B (en) Useful formulations of acid addition salt drugs.
HK1017999A1 (en) Slow-release pharmaceutical formulations containing mizolastin
EP0618222A3 (en) Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid.
SI0906101T1 (en) Slow-release pharmaceutical formulations containing mizolastin
GB9703607D0 (en) Pharmaceutical formulations
GB9621531D0 (en) Pharmaceutical formulations
GB9606372D0 (en) Pharmaceutical formulations
ITRM970049A0 (en) PROCEDURE FOR THE PREPARATION OF 2-IODOXYBENZOIC ACID.